منابع مشابه
Serious hematologic complications following erlotinib treatment.
BACKGROUND Erlotinib is an oral, small-molecule targeting therapy which inhibits epidermal growth factor tyrosine kinase receptors. Erlotinib has been administered for the treatment of advanced pancreatic cancer and non-small cell lung cancer. PATIENTS AND METHODS In the present report, unusual hematologic complications were detected after erlotinib was administered as second-line monotherapy...
متن کاملSerious Games Conferences and Events
Serious Games is an evolving subject for researchers and practitioners. More and more events take place with the focus or at least with some side attention given to this subject. We present some of these events as a support tool for potential authors in the selection of the best places to publish their work.
متن کاملEvaluation of Suspected Hematologic Adverse Drug Events
Many therapeutic drugs have been associated with hematologic adverse drug events (ADEs) in animals. Some drugs, notably chemotherapeutic agents and oxidant compounds, cause dose-dependent bone marrow suppression, while others induce idiosyncratic ADEs. Major mechanisms associated with ADEs include immuneor oxidant-mediated destruction of blood cells and toxic bone marrow injury. General classes...
متن کاملSerious safety events: Getting to Zero™.
To advance the goal of Getting to Zero and eliminating preventable harm, ASHRM is providing guidance for defining, investigating, and measuring serious safety events. The first step in this process is the recommendation for a common and standardized definition. A common definition for a serious safety event facilitates timely detection, rapid action, and future prevention. This paper outlines t...
متن کاملSerious Non-AIDS events: Immunopathogenesis and interventional strategies
Despite the major advances in the management of HIV infection, HIV-infected patients still have greater morbidity and mortality than the general population. Serious non-AIDS events (SNAEs), including non-AIDS malignancies, cardiovascular events, renal and hepatic disease, bone disorders and neurocognitive impairment, have become the major causes of morbidity and mortality in the antiretroviral ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Medical Association Journal
سال: 2004
ISSN: 0820-3946,1488-2329
DOI: 10.1503/cmaj.1041597